KLOW 80MG

KLOW is a co-lyophilized four-peptide research blend combining GHK-Cu, KPV, BPC-157, and TB-500 in a single 80 mg vial. Each component targets a distinct arm of the tissue-repair cascade. Reported research benefits: accelerated skin and soft-tissue healing through combined collagen synthesis (GHK-Cu) and cell migration (TB-500); reduced inflammation and cytokine release via KPV and BPC-157 activity in dermal and gut models; support for follicular regeneration and reduction of scarring; improved outcomes in colitis and IBD models through convergent anti-inflammatory pathways; enhanced angiogenesis into wound beds; and standardized molar ratios that reduce reconstitution error compared with four separate vials.